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Abstract: Skin fistula occurring after cardiac electronic device implantation is frequently related to pocket infection and this condition 
typically requires removal of device and lead(s). We report on a case of skin fistula occurring 3 weeks after internal cardioverter defibril-
lator replacement. Conservative management consisted of local care along with oral antibiotics without removal of device; this strategy 
resulted in complete healing and closure of the fistula.
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Introduction
Cardiac  implantable  electronic  device  (CIED) 
replacement  procedures  are  associated  with  higher 
complication rates compared to primo-implantation,1 
and dual and triple chamber CIED implantation are 
associated with higher complication rates compared 
to single chamber CIED.1 Infection related with CIED 
implantation typically mandates removal of all for-
eign material. We present a case of skin fistula occur-
ring  after  internal  cardioverter  defibrillator  (ICD) 
replacement, where the fistula healed with conserva-
tive management and without device explantation.
case presentation
A 75-year-old patient with dilated ischemic cardio-
myopathy had a single chamber ICD implanted for 
secondary  prevention;  he  was  admitted  for  device 
replacement because of battery depletion. Of note, 
the patient had 3 appropriate shocks for ventricular 
fibrillation during the last 6 months. The patient had 
no other significant co-morbidity conditions (ie, no 
diabetes, no renal failure).
The replacement procedure was achieved without 
any per-operative incident; of note, the inner layer of 
the device pocket was well demarcated, whitish, thick, 
resistant, brilliant and relatively impermeable to flu-
ids. The wound was closed superficially with metallic 
stitches; According to our wound care protocol, we 
do not use skin adhesive nor absorbable intracutane-
ous suture. Aspirin was halted seven days before the 
procedure and was resumed after stitches removal.
The patient was discharged on the second post-
  operative  day  and  wound  dressing  was  clean. 
A  ntibioprophylaxis started pre-operatively was con-
tinued for seven days; also, the patient was requested 
to undertake wound dressing every day with a regis-
tered nurse until stitches removal. On post-operative 
day 10, stitches were removed, wound healing was 
normal, there was no signs of infection, only a “mini-
mal”  pocket  hematoma  was  demonstrated  by  the 
“swinging sign” when compressing the pocket.
The  patient  presented  on  post-operative  day  20 
with a fistula located at the external edge of the wound 
that showed normal healing otherwise (Fig. 1). The 
patient was afebrile, there was no significant redness 
or swelling over the device; a thick reddish odorless 
fluid discharge from the fistula was taken for culture.
Despite  the  initial  hypothesis  of  pocket  infec-
tion and given that the patient was relatively device 
“dependent,” we decided to proceed with conservative 
therapy first: intensive local care and wound debride-
ment along with oral antibiotics (cefuroxime, 500 mg 
tid) without removal of the device. We informed the 
patient that if the conservative strategy was not suc-
cessful, a radical radical approach was to be imple-
mented (with removal of all material). The culture 
came positive for Staphylococcus Aureus (sensitive 
to cefuroxime) 72 hours later; nevertheless, we con-
tinued the conservative treatment plan and there was 
a gradual improvement then “complete” healing and 
closure of the fistula within 15 days.
Discussion
In this presented case, we hypothesize that the ini-
tial mechanism causing the formation of the fistula 
was a tension hematoma that drained to the skin 
with  subsequent  superficial  infection. The  hema-
toma could not resolve or expand probably because 
of the “hermetic” and rigid characteristics of the 
remodeled  inner  layer  of  the  pocket  and  finally 
it found an issue to the skin (fistula). In addition, 
despite  the  positive  microbiological  result,  there 
was  a  favorable  outcome  with  the  conservative 
approach and we considered—a posteriori—that it 
was a superficial infection secondary to the fistula. 
Figure 1. A fistula occurring 20 days after the procedure. Marks of the 
metallic stitches are still visible; also, the scar of the primo-implantation 
is visible.Fistula post defibrillator replacement
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In case of deep pocket infection, symptoms would 
include draining pus with redness and inflamma-
tion all around the area of the wound, also irrita-
tion related to pathogens and related toxins would 
slow and impede the healing process and complete 
removal of foreign materials is classically the only 
way to cure pocket infection.
Strict peri-procedural protocol must be applied in 
order to decrease CIED related complications, espe-
cially in patients with high risk of infection and/or 
hematoma (anticoagulant therapy, elderly, diabetes, 
renal failure, replacement procedures…). In this per-
spective, peri-operative antibioprophylaxis,2 anticoag-
ulant therapy management,3 implantation technique, 
wound dressing and patient education are of utmost 
importance. According to our institution policy, we 
do not use skin adhesives because we estimate they 
are not safe enough to achieve wound closure in the 
immediate post-operative period.4
Even though rare cases of pocket infection have 
been cured without removing the device,5 the clas-
sical management strategy consists of removal of all 
foreign materials to cure infection. In this presented 
case, we conclude that the fistula was related to a ten-
sion hematoma with subsequent superficial infection; 
conservative management resulted in complete heal-
ing without removal of device.
conclusion
Skin fistula occurring after CIED implantation can be 
managed in some cases without device explantation; 
in fact, not every fistula implies an underlying infec-
tion, it can simply be related to a tension hematoma. 
The occurrence of tension hematoma predisposes to 
fistula formation and the fistula also predisposes to 
secondary infection; accordingly, a case-by-case deci-
sion should be taken before explantation of device 
especially in dependent patient.
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